These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38534067)

  • 1. Correction to New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version).
    J Diabetes Investig; 2024 May; 15(5):643. PubMed ID: 38534067
    [No Abstract]   [Full Text] [Related]  

  • 2. New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes in Japan Diabetes Society (English version).
    Shimada A; Kawasaki E; Abiru N; Awata T; Oikawa Y; Osawa H; Kajio H; Kozawa J; Takahashi K; Chujo D; Noso S; Fukui T; Miura J; Yasuda K; Yasuda H; Imagawa A; Ikegami H
    Diabetol Int; 2024 Jan; 15(1):1-4. PubMed ID: 38264233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version).
    Shimada A; Kawasaki E; Abiru N; Awata T; Oikawa Y; Osawa H; Kajio H; Kozawa J; Takahashi K; Chujo D; Noso S; Fukui T; Miura J; Yasuda K; Yasuda H; Imagawa A; Ikegami H
    J Diabetes Investig; 2024 Feb; 15(2):254-257. PubMed ID: 38184802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes in Japan Diabetes Society (English version).
    Shimada A; Kawasaki E; Abiru N; Awata T; Oikawa Y; Osawa H; Kajio H; Kozawa J; Takahashi K; Chujo D; Noso S; Fukui T; Miura J; Yasuda K; Yasuda H; Imagawa A; Ikegami H
    Diabetol Int; 2024 Jul; 15(3):638-639. PubMed ID: 39101174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slowly Progressive Type 1 Diabetes Mellitus: Current Knowledge And Future Perspectives.
    Nishimura A; Matsumura K; Kikuno S; Nagasawa K; Okubo M; Mori Y; Kobayashi T
    Diabetes Metab Syndr Obes; 2019; 12():2461-2477. PubMed ID: 31819572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan.
    Yasui J; Kawasaki E; Tanaka S; Awata T; Ikegami H; Imagawa A; Uchigata Y; Osawa H; Kajio H; Kawabata Y; Shimada A; Takahashi K; Yasuda K; Yasuda H; Hanafusa T; Kobayashi T;
    PLoS One; 2016; 11(5):e0155643. PubMed ID: 27177031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological changes in the pancreas of fulminant type 1 diabetes and slowly progressive insulin-dependent diabetes mellitus (SPIDDM): innate immunity in fulminant type 1 diabetes and SPIDDM.
    Kobayashi T; Nishida Y; Tanaka S; Aida K
    Diabetes Metab Res Rev; 2011 Nov; 27(8):965-70. PubMed ID: 22069294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slowly progressive insulin-dependent (type 1) diabetes positive for anti-GAD antibody ELISA test may be strongly associated with a future insulin-dependent state.
    Oikawa Y; Tanaka H; Uchida J; Atsumi Y; Osawa M; Katsuki T; Kawai T; Shimada A
    Endocr J; 2017 Feb; 64(2):163-170. PubMed ID: 27760891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin intervention to preserve beta cells in slowly progressive insulin-dependent (type 1) diabetes mellitus.
    Kobayashi T; Maruyama T; Shimada A; Kasuga A; Kanatsuka A; Takei I; Tanaka S; Yokoyama J
    Ann N Y Acad Sci; 2002 Apr; 958():117-30. PubMed ID: 12021091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of positive rates between glutamic acid decarboxylase antibodies and ElisaRSR™ 3 Screen ICA™ in recently obtained sera from patients who had been previously diagnosed with slowly progressive type 1 diabetes.
    Takehana N; Fukui T; Mori Y; Hiromura M; Terasaki M; Ohara M; Takada M; Tomoyasu M; Ito Y; Kobayashi T; Yamagishi SI
    J Diabetes Investig; 2023 Jul; 14(7):856-863. PubMed ID: 37082800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct Inflammatory Changes of the Pancreas of Slowly Progressive Insulin-dependent (Type 1) Diabetes.
    Aida K; Fukui T; Jimbo E; Yagihashi S; Shimada A; Oikawa Y; Mori Y; Fujii T; Nishida Y; Koyama R; Kobayashi T
    Pancreas; 2018 Oct; 47(9):1101-1109. PubMed ID: 30192315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A patient with primary biliary cirrhosis complicated with slowly progressive insulin-dependent diabetes mellitus.
    Nakasone H; Kinjo K; Yamashiro M; Kamiyama T; Kamiyama S; Miyazato H; Matsushita T; Arakawa Y; Ohshiro T; Toma S; Chinen K; Yamashiro M; Miyagi M; Makishi T; Hokama A; Sakugawa H; Kinjo F; Saito A
    Intern Med; 2003 Jun; 42(6):496-9. PubMed ID: 12857047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible Long-Term Efficacy of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Slowly Progressive Type 1 Diabetes (SPIDDM) in the Stage of Non-Insulin-Dependency: An Open-Label Randomized Controlled Pilot Trial (SPAN-S).
    Awata T; Shimada A; Maruyama T; Oikawa Y; Yasukawa N; Kurihara S; Miyashita Y; Hatano M; Ikegami Y; Matsuda M; Niwa M; Kazama Y; Tanaka S; Kobayashi T
    Diabetes Ther; 2017 Oct; 8(5):1123-1134. PubMed ID: 28929327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes.
    Kobayashi T; Tanaka S; Okubo M; Nakanishi K; Murase T; Lernmark A
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4768-75. PubMed ID: 14557453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
    Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
    Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of titer of GAD antibodies for further progression of beta cell dysfunction in slowly progressive insulin-dependent (type 1) diabetes (SPIDDM).
    Tanaka S; Okubo M; Nagasawa K; Takizawa S; Ichijo M; Ichijo S; Kaneshige M; Aida K; Shimura H; Mori Y; Kobayashi T
    Diabetol Int; 2016 Mar; 7(1):42-52. PubMed ID: 30603242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prader-Willi Syndrome with Slowly Progressive Insulin-dependent Diabetes Mellitus.
    Tomoda Y; Okauchi Y; Deguchi A; Takenoshita Y; Iwahashi H; Mineo I
    Intern Med; 2021 May; 60(9):1423-1426. PubMed ID: 33250457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pioglitazone may accelerate disease course of slowly progressive type 1 diabetes.
    Shimada A; Shigihara T; Okubo Y; Katsuki T; Yamada Y; Oikawa Y
    Diabetes Metab Res Rev; 2011 Nov; 27(8):951-3. PubMed ID: 22069291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bi-glandular and persistent enterovirus infection and distinct changes of the pancreas in slowly progressive type 1 diabetes mellitus.
    Fukui T; Kobayashi T; Jimbo E; Aida K; Shimada A; Oikawa Y; Mori Y; Fujii T; Koyama R; Kobayashi K; Takeshita A; Yagihashi S
    Sci Rep; 2023 Apr; 13(1):6977. PubMed ID: 37117225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between HLA haplotype and BMI change in Japanese slowly progressive type 1 diabetes patients.
    Hoshina S; Miura J; Uchigata Y
    Diabetes Res Clin Pract; 2017 Feb; 124():81-83. PubMed ID: 28110239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.